Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe
Spotlight

Marijuana Rescheduled by DOJ and DEA

FDA-approved products and state-regulated medical products are now Schedule III, effective immediately.
Read More →
April 27, 2026
Spotlight

Insights from the 2026 IAIABC Forum

Discussions centered around evolving approaches to carrier compliance and oversight, reflecting an increasing shift toward data-driven system alignment.
Read More →
April 27, 2026
Spotlight

Insights From the Delaware/Pennsylvania WCRB Forum

Among many educational sessions, Sandy Shtab, Healthesystems VP of Industry and State Affairs, joined a panel on Medical Experience.
Read More →
April 27, 2026

White House Issues Executive Order on Psychedelics

The order seeks to accelerate clinical trials, data sharing, drug approvals, and possibly rescheduling.
Read More →
April 27, 2026

Minnesota Publishes Drug Price Transparency Report

Prescription drug list prices increased 23% in the last year, far outpacing inflation.
Read More →
April 27, 2026

New York Could Exclude Unpaid Interns from Workers’ Comp

Such interns would not be considered employees, meaning they would not be entitled to various employee benefits.
Read More →
April 27, 2026

Oklahoma Employers Can Terminate Employees for Any Marijuana Use

Positive drug tests, even for medical use, can result in termination. The bill also updates rules around safety sensitive positions.
Read More →
April 27, 2026

Pennsylvania Advisory Council Signals Legislative Attention Needed on Topical Cap

Senate Bill 1215 was discussed, and it appears unlikely the proposed reimbursement caps will be passed.
Read More →
April 20, 2026

California P&T Committee Recommends Formulary Updates

The committee issued new recommendations related to 300 mg ibuprofen, gabapentin and pregabalin, cyclobenzaprine, and tizanidine.
Read More →
April 20, 2026
1 2 3 … 51

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

Rescheduling Questions: How the Marijuana Landscape Could Soon Change

A White House Executive Order to expedite the rescheduling of marijuana may introduce significant implications for clinical research, drug development, and downstream utilization.
Read More

State of the Nation: Summer 2026

Healthesystems’ Sandy Shtab examines key workers’ comp policy trends, from PBM regulation and AI oversight to marijuana rescheduling and injured worker engagement.
Read More

Pennsylvania Proposes Reimbursement Caps for Compounds and Topicals

The bill would create a $400, 30-day supply cap for compound drugs.
Read More

New Jersey Proposes Marijuana Reimbursement in Workers’ Comp and Group Health

Companion bills S3984 and A1023 would require health insurance coverage for the medical use of cannabis under certain circumstances.
Read More

Florida Appeals Court Rules in Favor of Carriers and Employers on Physician-Dispensed Drugs

While injured workers have an absolute choice over their pharmacist, physicians are not considered pharmacists and therefore not entitled to reimbursement.
Read More

WCRI Publishes National Repository on Prescription Drug Regulations

While the report addresses multiple topics, a significant focus was given to the expanding role of pharmacists as a healthcare provider.
Read More
1 2 3 … 50
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle